AP-1 imprints a reversible transcriptional programme of senescent cells von Martínez-Zamudio, Ricardo Iván, Roux, Pierre-François, de Freitas, José Américo N.L.F., Robinson, Lucas, Doré, Gregory, Sun, Bin, Belenki, Dimitri, Milanovic, Maja, Herbig, Utz, Schmitt, Clemens A., Gil, Jesús, Bischof, Oliver

Volltext

Hepatitis C von Martinello, Marianne, Solomon, Sunil S, Terrault, Norah A, Dore, Gregory J

Volltext

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression von Waziry, Reem, Hajarizadeh, Behzad, Grebely, Jason, Amin, Janaki, Law, Matthew, Danta, Mark, George, Jacob, Dore, Gregory J.

Volltext

Direct-acting antiviral agents for HCV infection affecting people who inject drugs von Grebely, Jason, Hajarizadeh, Behzad, Dore, Gregory J.

Volltext

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection von Phetsouphanh, Chansavath, Darley, David R., Wilson, Daniel B., Howe, Annett, Munier, C. Mee Ling, Patel, Sheila K., Juno, Jennifer A., Burrell, Louise M., Kent, Stephen J., Dore, Gregory J., Kelleher, Anthony D., Matthews, Gail V.

Volltext

Necroptosis microenvironment directs lineage commitment in liver cancer von Seehawer, Marco, Heinzmann, Florian, D’Artista, Luana, Harbig, Jule, Roux, Pierre-François, Hoenicke, Lisa, Dang, Hien, Klotz, Sabrina, Robinson, Lucas, Doré, Grégory, Rozenblum, Nir, Kang, Tae-Won, Chawla, Rishabh, Buch, Thorsten, Vucur, Mihael, Roth, Mareike, Zuber, Johannes, Luedde, Tom, Sipos, Bence, Longerich, Thomas, Heikenwälder, Mathias, Wang, Xin Wei, Bischof, Oliver, Zender, Lars

Volltext

Hepatitis C virus elimination: laying the foundation for achieving 2030 targets von Dore, Gregory J., Bajis, Sahar

Volltext

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis von Lockart, Ian, Yeo, Malcolm G. H., Hajarizadeh, Behzad, Dore, Gregory J., Danta, Mark, Abe, Kazumichi, Carrat, Fabrice, Lusivika‐Nzinga, Clovis, Degasperi, Elisabetta, Di Marco, Vito, Hou, Jinlin, Howell, Jessica, Janjua, Naveed Z, Wong, Stanley, Kumada, Takashi, Lleo, Ana, Persico, Marcello, Lok, Anna S, Wei, Lai, Yang, Ming, Nabatchikova, Ekaterina, Nguyen, Mindie H, Antonio Pineda, Juan, Reig, María, Shiha, Gamal, Yu, Ming‐Lung, Tsai, Pei‐Chien

Volltext

Transcript tinkering: RNA modifications in protozoan parasites von Vignolini, Tiziano, Couble, Justine E.C., Doré, Grégory R.G., Baumgarten, Sebastian

Volltext

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia von Iversen, Jenny, Dore, Gregory J., Catlett, Beth, Cunningham, Philip, Grebely, Jason, Maher, Lisa

Volltext

Can hepatitis C virus infection be eradicated in people who inject drugs? von Grebely, Jason, Dore, Gregory J.

Volltext

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications von Kwon, Jisoo A., Dore, Gregory J., Hajarizadeh, Behzad, Alavi, Maryam, Valerio, Heather, Grebely, Jason, Guy, Rebecca, Gray, Richard T.

Volltext

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis von Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

Volltext

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double... von Jacobson, Ira M, Prof, Dore, Gregory J, Prof, Foster, Graham R, Prof, Fried, Michael W, Prof, Radu, Monica, MD, Rafalsky, Vladimir V, Prof, Moroz, Larysa, Prof, Craxi, Antonio, Prof, Peeters, Monika, MSc, Lenz, Oliver, PhD, Ouwerkerk-Mahadevan, Sivi, PhD, De La Rosa, Guy, MD, Kalmeijer, Ronald, MD, Scott, Jane, PhD, Sinha, Rekha, PhD, Beumont-Mauviel, Maria, PhD

Volltext

Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels von Grebely, Jason, Oser, Megan, Taylor, Lynn E., Dore, Gregory J.

Volltext

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+) von Leroy, Vincent, Angus, Peter, Bronowicki, Jean‐Pierre, Dore, Gregory J., Hezode, Christophe, Pianko, Stephen, Pol, Stanislas, Stuart, Katherine, Tse, Edmund, McPhee, Fiona, Bhore, Rafia, Jimenez‐Exposito, Maria Jesus, Thompson, Alexander J.

Volltext

Hepatitis C Virus Therapeutic Development: In Pursuit of "Perfectovir" von Dore, Gregory J., Feld, Jordan J.

Volltext

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review von Bajis, Sahar, Dore, Gregory J., Hajarizadeh, Behzad, Cunningham, Evan B., Maher, Lisa, Grebely, Jason

Volltext

Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and Instructive von Dore, Gregory J., Cowie, Benjamin

Volltext

The changing therapeutic landscape for hepatitis C von Dore, Gregory J

Volltext